Logo
Salubris Biotherapeutics

Senior Director/Vice President, Preclinical Pharmacology & Toxicology

Salubris Biotherapeutics, Gaithersburg

Save Job

Benefits

  • 401(k) matching
  • Competitive salary
  • Dental insurance
  • Free food & snacks
  • Health insurance
  • Paid time off

Position Overview

Salubris Biotherapeutics is seeking a visionary and experienced leader to join our team as Senior Director or Vice President, Preclinical Pharmacology & Toxicology .

This foundational leadership role offers the opportunity to further establish and lead the Preclinical Pharmacology, Pharmacometrics, and Toxicology function, driving research programs from lead optimization through IND submission.

The SD/VP will be responsible for integrating nonclinical pharmacology, toxicology, and pharmacokinetics into the company’s R&D strategy, ensuring alignment with regulatory and scientific standards. This strategic leadership role guides non‑clinical assessments from late research development through IND/CTA submissions and will have a significant and lasting impact on the company’s scientific direction and future success.

Key Responsibilities

  • Strategic Program Leadership: Serve as a key strategic leader, partnering with the CSO to shape preclinical development strategy across the portfolio. Drive the strategic vision for advancing programs from late‑stage discovery through IND/CTA submission, ensuring alignment with corporate objectives and competitive positioning. Anticipate regulatory and scientific challenges, and proactively develop risk mitigation strategies to accelerate program timelines.
  • Preclinical Study Oversight: Design, manage, and interpret pharmacology, PK/PD, and toxicology studies (GLP/non‑GLP) to support program advancement. Oversee CRO partnerships, protocol development, study monitoring, and regulatory documentation to deliver high‑quality nonclinical data packages.
  • Cross‑Functional Integration: Lead cross‑functional collaboration with Bioanalytical, CMC, and Clinical teams to develop integrated nonclinical safety, translational science and CMC development strategies. Ensure seamless translation of preclinical findings into clinical development plans.
  • Scientific Excellence & Team Development: Mentor and develop internal team members, building organizational capabilities in disease‑ and target‑relevant efficacy studies, PK/PD/biomarker strategies, and translational approaches across cardiovascular/metabolic and oncology therapeutic areas.

Required Qualifications

  • PhD in Biology, Biochemistry, Biomedical Sciences, Pharmacology, Toxicology, Pharmaceutical Sciences, or related scientific discipline.
  • 10+ years of relevant pharmaceutical/biotechnology industry experience, including 5+ years in a leadership capacity within preclinical pharmacology, toxicology, and/or DMPK.
  • Demonstrated ability as program lead to advance programs from lead optimization to IND with complex biologics, such as antibodies, and/or antibody conjugates (ADCs, AOCs).
  • Deep understanding of in vivo pharmacology and toxicology.
  • Solid working knowledge in bioanalysis, PK/PD, and DMPK. Relevant experience with both biologics and small molecules is a strong plus.
  • Experience delivering high‑quality preclinical/nonclinical data packages for drug candidate selection and IND‑enabling studies.
  • Experience with cardiovascular/metabolic therapeutic area or oncology preferred.

Skills & Competencies

  • Strong strategic thinking and scientific judgment with excellent problem‑solving capabilities.
  • Excellent communication skills with the ability to distill complex scientific analyses into clear, actionable recommendations for diverse audiences.
  • Strong interpersonal skills with the ability to motivate, influence, and lead cross‑functional teams in a matrixed environment.
  • Demonstrated ability to work collaboratively and influence at all levels of the organization.
  • Independent, self‑motivated leader with the ability to work in a fast‑paced, team‑based drug discovery and development environment.

About Salubris Biotherapeutics

Salubris Biotherapeutics, Inc. (or SalubrisBio) is a clinical‑stage biotechnology company dedicated to the discovery and global development of novel biologic therapeutics for the treatment of cancer, cardiovascular, and metabolic diseases. We are advancing a robust complex biologics pipeline including antibody‑drug‑conjugate and antibody‑fusion programs, with a commitment to transforming patient outcomes through scientific excellence and innovation.

We offer a competitive compensation package including base salary, performance bonus, equity participation, and comprehensive benefits.

SalubrisBio is an equal opportunity employer committed to diversity and inclusion in the workplace.

#J-18808-Ljbffr